top of page

Two novel variants in GRN: the relevance of CNV analysis and genetic screening in FTLD patients with a negative family history

De Houwer JFH, Dopper EGP, Rajicic A, van Buuren R, Arcaro M, Galimberti D, Breedveld GJ, Wilke M, van Minkelen R, Jiskoot LC, van Swieten JC, Donker Kaat L, Seelaar H.

J Neurol. 2024 Dec 16;272(1):64. doi: 10.1007/s00415-024-12758-7.

2024

PMID

39680222

CBD

Two novel variants in GRN: the relevance of CNV analysis and genetic screening in FTLD patients with a negative family history
bottom of page